Risk Stratification of Patients Presenting With Upper Gastrointestinal Bleeding to the Emergency Department Using AIMS65 Score and Red Cell Distribution Width
NCT ID: NCT04825977
Last Updated: 2021-04-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
348 participants
OBSERVATIONAL
2018-08-01
2020-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predictive Role of Red Cell Distribution Width in Upper GI Bleeding Patients
NCT03119987
Transfusion in Gastrointestinal Bleeding
NCT02105532
Efficacy of Tranexamic Acid in Upper Gastrointestinal Bleeding
NCT04788121
Tranexamic Acid for Upper Gastrointestinal Bleeding
NCT01713101
Gastrointestinal Bleeding Management
NCT02403076
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Various clinical prediction scores help in risk stratifying such patients. Among the scores, AIMS65 score is the easy to use score and has good mortality predictive accuracy. RDW, once thought as marker of chronic blood loss has recently been identified as a good prognostic indicator as well as good predictor of mortality in conditions where there is acute blood loss.
Both AIMS65 score and RDW value have been used separately as a predictor of morbidity and mortality in patients with UGIB. But there are not much studies so far evaluating their combined role as marker of predicting mortality as well as high risk among UGIB patients. Hence there is a need for a study to know the predictive value of combination of AIMS6S score and RDW in patients presenting to ED with symptoms of UGIB not been much studies comparing the relationship between RDW and upper GI bleed.
The rationale of this study in UGIB patients is to assess whether the prediction of mortality and morbidity using AIMS65 score improves when used in combination with RDW in the emergency department setting.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
RISK STRATIFICATION USING AIMS65 SCORE AND RDW
Risk Statification of patients presenting with upper gastrointestinal bleeding to the emergency department using AIMS65 score and Red cell Distribution Width.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age more than 18 years of age
Exclusion Criteria
2. Patients with known hematological disorders
3. Patients in which endoscopy or blood transfusion is done outside
4. Patients in which RDW value and laboratory parameters required for AIMS65 score are not available.
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jubilee Mission Medical College and Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr.Vijay Chanchal A B
Junior Resident
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Siju V Abraham, MD
Role: STUDY_CHAIR
Jubilee Mission Medical College
Rajeev P C, MD
Role: STUDY_DIRECTOR
Jubilee Mission Medical College
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jubilee Mission Medical College and Research Institute
Thrissur, Kerala, India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CTRI/2019/03/018127
Identifier Type: REGISTRY
Identifier Source: secondary_id
35/18/IEC/JMMC&RI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.